← 返回

甘露糖代谢重塑 T 细胞分化以增强抗肿瘤免疫

英文原题:Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity.

查看英文原题

Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity.

PubMed 2024/12/05(内容时间) Cancer Cell Q1 · IF 56.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

细胞代谢状态深刻影响T细胞的分化、持久性和抗肿瘤疗效。我们对T细胞的单细胞代谢分析揭示,甘露糖代谢减弱是T细胞功能障碍的一个突出特征。相反,通过D-甘露糖补充在过继转移的T细胞中实验性增强/恢复甘露糖代谢,可在体外和体内增强抗肿瘤活性并限制耗竭分化。在机制上,D-甘露糖处理诱导细胞内代谢重编程,并增加OGT介导的β-catenin的O-GlcNAc糖基化,从而维持Tcf7表达和表观遗传干性,进而促进T细胞中的干样程序。此外,在体外扩增过程中补充D-甘露糖可产生具有干性特征的过继治疗T细胞产品,即使在长期大规模扩增后,其仍表现出增强的抗肿瘤疗效。这些发现揭示了细胞内在的甘露糖代谢是CD8+ T细胞命运的生理调节因子,将增殖/扩增与分化解偶联,并强调了甘露糖调控在癌症免疫治疗中的治疗潜力。

展开英文摘要原文

Cellular metabolic status profoundly influences T cell differentiation, persistence, and anti-tumor efficacy.

Our single-cell metabolic analyses of T cells reveal that diminished mannose metabolism is a prominent feature of T cell dysfunction. Conversely, experimental augmentation/restoration of mannose metabolism in adoptively transferred T cells via D-mannose supplementation enhances anti-tumor activity and restricts exhaustion differentiation both in vitro and in vivo.

Mechanistically, D-mannose treatment induces intracellular metabolic programming and increases the O-GlcNAc transferase (OGT)-mediated O-GlcNAcylation of β-catenin, which preserves Tcf7 expression and epigenetic stemness, thereby promoting stem-like programs in T cells.

Furthermore, in vitro expansion with D-mannose supplementation yields T cell products for adoptive therapy with stemness characteristics, even after extensive long-term expansion, that exhibits enhanced anti-tumor efficacy.

These findings reveal cell-intrinsic mannose metabolism as a physiological regulator of CD8 + T cell fate, decoupling proliferation/expansion from differentiation, and underscoring the therapeutic potential of mannose modulation in cancer immunotherapy.

论文信息

作者
Qiu Y、Su Y、Xie E、Cheng H、Du J、Xu Y、Pan X、Wang Z
第一作者单位
National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215123, Jiangsu, China; Key Laboratory of Synthetic Biology Regulatory Elements, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215123, Jiangsu, China.China
通讯作者单位
National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215123, Jiangsu, China; Key Laboratory of Synthetic Biology Regulatory Elements, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215123, Jiangsu, China. Electronic address: lgd@ism.cams.cn.China
期刊
Cancer cell2025 Jan 13
原文标识
PubMed 39642888 · DOI 10.1016/j.ccell.2024.11.003